Sodium Divalproate API

Name	Sodium Divalproate
Chinese name	双丙戊酸钠
Cas Number	76584-70-8
Source	India
Qualifications	USDMF/-/-/-/-

In 2003, Sanofi-Aventis’s Sodium Valproate Sustained-Release Tablet "Debajin" led the market when it entered the Chinese market; in the current domestic valproate drug market, 90% of the sales amount was Ba Jin" possesses. The most commonly used valproate abroad is not sodium valproate, but sodium divalproate. Compared with sodium valproate, divalproate sodium has replaced the traditional market position of sodium valproate due to lighter gastrointestinal side effects and fewer drug interactions. Divalproex sodium under Abbott and Sanofi-Aventis (respectively responsible for sales in the US market and outside the US) are "blockbuster" drugs. Sodium valproate and sodium divalproex are both first-line drugs recommended by foreign epilepsy treatment guidelines, with good clinical prospects.

Hot Tags: sodium divalproate api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Lapatinib Ditosylate API, Clofarabine API, Tetrabenazine API, Rasagiline Mesylate API, Fulvestrant API, Temozolomide API

• Previous: Vitamin B6 API
• Next: Nafuraphine API